By May 1, 2020, it became mandatory for all aged care workers and visitors (>6mths) to enter an aged care facility in Australia to have received a flu vaccine, this prompted many workers to quit, and families became unable to visit their loved-ones. [1, 2]
The department of health stated that “COVID-19 is a health risk for older people”, and the new restrictions are to protect them.
This is just in time to introduce the new flu vaccines grown in canine kidney cells [called cell culture technology] instead of the chicken embryos, which is more time consuming. Interestingly, canines are known to harbor coronaviruses [3, 4]
In the UK just months before the “new Flucelvax Tetra jab, from Maidenhead-based company Seqirus” was introduced it “dispenses with the need for eggs. Instead, the virus is grown in huge vats of [modified dog kidney] cells in a plant in North Carolina, in the U.S.” Fluad Quad by Seqirus was approved by TGA on September 24, 2019. [product insert from FDA]
Fluad Quad and Fluad Tetra are same product, and in Australia the only market approved for this new product was those over 65 years – the age of those in nursing homes!
The flu vaccine itself results in 0.6% deaths according to manufacturer product inserts [@47.50].